CHRONIC ADMINISTRATION OF CILOSTAZOL IN PATIENTS WITH INTERMITTENT CLAUDICATION

间歇性跛行患者长期服用西洛他唑

• 批准号: 3786559
• 负责人: JOHN M. PORTER
• 金额: --
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3786559
• 关键词: artery occlusion; azoles; cardiovascular agents; cardiovascular disorder chemotherapy; drug administration rate /duration; drug screening /evaluation; gait; human subject; longitudinal human study; peripheral blood vessel disorder

This is a prospective, long-term, open-label study to assess the safety and efficacy of chronic administration of cilostazol in patients with intermittent claudication secondary to chronic occlusive arterial disease.

这是一项前瞻性、长期、开放标签研究，旨在评估 西洛他唑长期给药在慢性前列腺炎患者中的疗效 继发于慢性动脉闭塞的间歇性跛行 疾病